| Regina R Escano, AUD | |
|
2300 M St Nw, 4th Floor, Washington, DC 20037-1434 | |
| (202) 741-3275 | |
| Not Available |
| Full Name | Regina R Escano |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 2300 M St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750782116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD000140 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Regina R Escano, AUD 2300 M St Nw, 4th Floor, Washington, DC 20037-1434 Ph: (202) 741-3275 | Regina R Escano, AUD 2300 M St Nw, 4th Floor, Washington, DC 20037-1434 Ph: (202) 741-3275 |
News Archive
The marshmallow test is a simple social-science tests that was developed by Stanford psychologist Walter Mischel around six decades back. In this test a marshmallow is put before a child and they are told that they can have a second one if they can manage to wait 15 minutes before having the first one.
FDA will waive rules that prohibit advisory panel members from having financial ties to companies whose products are being reviewed to allow six physicians with ties to Johnson & Johnson and other heart device manufacturers to serve on a panel examining the possible health risks of drug-eluting stents, Bloomberg/South Florida Sun-Sentinel reports.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.
› Verified 9 days ago
Sheela L Stuart, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-5600 | |
Karen Tal Woolman, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5627 | |
Mrs. Elise Ney, M.A, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 29, Washington, DC 20016 Phone: 202-362-4300 | |
Ashley King, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2300 M St Nw, Washington, DC 20037 Phone: 410-991-4749 | |
Dr. Claire Bernstein, PH.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Washington, DC 20002 Phone: 301-509-0722 | |
Hearing 4life Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw Ste 125, Washington, DC 20016 Phone: 202-621-6374 | |
Kelsey Ann Ambrose, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2300 M St Nw Fl 4, Washington, DC 20037 Phone: 202-741-3275 |